Steroid users can undo at least some of the damage if they simply stop taking them. 

The next-generation surgical device from Corcym was associated with consistent durability and positive safety data. For example, freedom from structural valve deterioration was seen in 99.7% of patients.

The experimental technology could help clinicians perform CABG procedures without needing to harvest vessels from the patient.

The studies all answer key clinical questions, highlighting a variety of new technologies, drugs and techniques. 

Wearable trackers found that PE patients were more active if they underwent mechanical thrombectomy than if they were just put on anticoagulation therapy alone.

There is still not a clear consensus on how to best treat this atypical cardiac presentation.

Blocking the enzyme succinate dehydrogenase can flip a metabolic switch in adult mice to prompt cardiomyocyte regeneration.

The new device, designed to perform mitral valve repair in patients with functional MR, was co-invented by cardiologist Samir Kapadia, MD, and surgeon Jose Navia, MD.